Melinda A Engevik1, Heather A Danhof2, Jennifer Auchtung3, Bradley T Endres4, Wenly Ruan5, Eugénie Bassères4, Amy C Engevik6, Qinglong Wu5, Maribeth Nicholson7, Ruth Ann Luna5, Kevin W Garey4, Sue E Crawford2, Mary K Estes8, Renate Lux9, Mary Beth Yacyshyn10, Bruce Yacyshyn10, Tor Savidge5, Robert A Britton2, James Versalovic5. 1. Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas; Texas Children's Microbiome Center, Department of Pathology, Texas Children's Hospital, Houston, Texas. Electronic address: melinda.engevik@bcm.edu. 2. Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas. 3. Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas; Department of Food Science and Technology, University of Nebraska-Lincoln, Lincoln, Nebraska. 4. Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, Texas. 5. Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas; Texas Children's Microbiome Center, Department of Pathology, Texas Children's Hospital, Houston, Texas. 6. Department of Surgical Sciences, Vanderbilt University Medical Center, Nashville, Tennessee. 7. Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee. 8. Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas; Department of Surgical Sciences, Vanderbilt University Medical Center, Nashville, Tennessee. 9. Department of Periodontics, University of California Los Angeles School of Dentistry, Los Angeles, California. 10. Department of Medicine Division of Digestive Diseases University of Cincinnati College of Medicine, Cincinnati, Ohio.
Abstract
BACKGROUND & AIMS: Although Clostridioides difficile infection (CDI) is known to involve the disruption of the gut microbiota, little is understood regarding how mucus-associated microbes interact with C difficile. We hypothesized that select mucus-associated bacteria would promote C difficile colonization and biofilm formation. METHODS: To create a model of the human intestinal mucus layer and gut microbiota, we used bioreactors inoculated with healthy human feces, treated with clindamycin and infected with C difficile with the addition of human MUC2-coated coverslips. RESULTS: C difficile was found to colonize and form biofilms on MUC2-coated coverslips, and 16S rRNA sequencing showed a unique biofilm profile with substantial cocolonization with Fusobacterium species. Consistent with our bioreactor data, publicly available data sets and patient stool samples showed that a subset of patients with C difficile infection harbored high levels of Fusobacterium species. We observed colocalization of C difficile and F nucleatum in an aggregation assay using adult patients and stool of pediatric patients with inflammatory bowel disease and in tissue sections of patients with CDI. C difficile strains were found to coaggregate with F nucleatum subspecies in vitro; an effect that was inhibited by blocking or mutating the adhesin RadD on Fusobacterium and removal of flagella on C difficile. Aggregation was shown to be unique between F nucleatum and C difficile, because other gut commensals did not aggregate with C difficile. Addition of F nucleatum also enhanced C difficile biofilm formation and extracellular polysaccharide production. CONCLUSIONS: Collectively, these data show a unique interaction of between pathogenic C difficile and F nucleatum in the intestinal mucus layer.
BACKGROUND & AIMS: Although Clostridioides difficile infection (CDI) is known to involve the disruption of the gut microbiota, little is understood regarding how mucus-associated microbes interact with C difficile. We hypothesized that select mucus-associated bacteria would promote C difficile colonization and biofilm formation. METHODS: To create a model of the human intestinal mucus layer and gut microbiota, we used bioreactors inoculated with healthy human feces, treated with clindamycin and infected with C difficile with the addition of human MUC2-coated coverslips. RESULTS: C difficile was found to colonize and form biofilms on MUC2-coated coverslips, and 16S rRNA sequencing showed a unique biofilm profile with substantial cocolonization with Fusobacterium species. Consistent with our bioreactor data, publicly available data sets and patient stool samples showed that a subset of patients with C difficile infection harbored high levels of Fusobacterium species. We observed colocalization of C difficile and F nucleatum in an aggregation assay using adult patients and stool of pediatric patients with inflammatory bowel disease and in tissue sections of patients with CDI. C difficile strains were found to coaggregate with F nucleatum subspecies in vitro; an effect that was inhibited by blocking or mutating the adhesin RadD on Fusobacterium and removal of flagella on C difficile. Aggregation was shown to be unique between F nucleatum and C difficile, because other gut commensals did not aggregate with C difficile. Addition of F nucleatum also enhanced C difficile biofilm formation and extracellular polysaccharide production. CONCLUSIONS: Collectively, these data show a unique interaction of between pathogenic C difficile and F nucleatum in the intestinal mucus layer.
Authors: D J Davido; F Richter; F Boxberger; A Stahl; T Menzel; H Lührs; S Löffler; G Dusel; U R Rapp; W Scheppach Journal: Eur J Cancer Prev Date: 2001-08 Impact factor: 2.497
Authors: Eric J Battaglioli; Vanessa L Hale; Jun Chen; Patricio Jeraldo; Coral Ruiz-Mojica; Bradley A Schmidt; Vayu M Rekdal; Lisa M Till; Lutfi Huq; Samuel A Smits; William J Moor; Yava Jones-Hall; Thomas Smyrk; Sahil Khanna; Darrell S Pardi; Madhusudan Grover; Robin Patel; Nicholas Chia; Heidi Nelson; Justin L Sonnenburg; Gianrico Farrugia; Purna C Kashyap Journal: Sci Transl Med Date: 2018-10-24 Impact factor: 17.956
Authors: Ekaterina G Semenyuk; Valeriy A Poroyko; Pehga F Johnston; Sara E Jones; Katherine L Knight; Dale N Gerding; Adam Driks Journal: Infect Immun Date: 2015-08-31 Impact factor: 3.441
Authors: Sandor E Karpathy; Xiang Qin; Jason Gioia; Huaiyang Jiang; Yamei Liu; Joseph F Petrosino; Shailaja Yerrapragada; George E Fox; Susan Kinder Haake; George M Weinstock; Sarah K Highlander Journal: PLoS One Date: 2007-08-01 Impact factor: 3.240
Authors: Alyxandria M Schubert; Mary A M Rogers; Cathrin Ring; Jill Mogle; Joseph P Petrosino; Vincent B Young; David M Aronoff; Patrick D Schloss Journal: MBio Date: 2014-05-06 Impact factor: 7.867
Authors: Janiece S Glover; Brittney D Browning; Taylor D Ticer; Amy C Engevik; Melinda A Engevik Journal: Front Physiol Date: 2022-05-24 Impact factor: 4.755
Authors: Melinda A Engevik; Heather A Danhof; Wenly Ruan; Amy C Engevik; Alexandra L Chang-Graham; Kristen A Engevik; Zhongcheng Shi; Yanling Zhao; Colleen K Brand; Evan S Krystofiak; Susan Venable; Xinli Liu; Kendal D Hirschi; Joseph M Hyser; Jennifer K Spinler; Robert A Britton; James Versalovic Journal: mBio Date: 2021-03-02 Impact factor: 7.867
Authors: Jessica Queen; Jada C Domingue; James Robert White; Courtney Stevens; Barath Udayasuryan; Tam T D Nguyen; Shaoguang Wu; Hua Ding; Hongni Fan; Madison McMann; Alina Corona; Tatianna C Larman; Scott S Verbridge; Franck Housseau; Daniel J Slade; Julia L Drewes; Cynthia L Sears Journal: mBio Date: 2022-02-08 Impact factor: 7.867
Authors: Sarah Tomkovich; Ana Taylor; Jacob King; Joanna Colovas; Lucas Bishop; Kathryn McBride; Sonya Royzenblat; Nicholas A Lesniak; Ingrid L Bergin; Patrick D Schloss Journal: mSphere Date: 2021-09-29 Impact factor: 4.389